These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28905837)

  • 1.
    Cho IH; Kim HD; Jung SJ; Park TK
    Indian J Ophthalmol; 2017 Sep; 65(9):877-879. PubMed ID: 28905837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal basement membrane abnormalities and the retinopathy of Alport syndrome.
    Savige J; Liu J; DeBuc DC; Handa JT; Hageman GS; Wang YY; Parkin JD; Vote B; Fassett R; Sarks S; Colville D
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1621-7. PubMed ID: 19850830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MACULAR HOLES, VITELLIFORM LESIONS, AND MIDPERIPHERAL RETINOSCHISIS IN ALPORT SYNDROME.
    Thomas AS; Baynham JT; Flaxel CJ
    Retin Cases Brief Rep; 2016; 10(2):109-11. PubMed ID: 26200386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bull's eye and pigment maculopathy are further retinal manifestations of an abnormal Bruch's membrane in Alport syndrome.
    Savige J; Wang Y; Crawford A; Smith J; Symons A; Mack H; Nicholls K; Wilson D; Colville D
    Ophthalmic Genet; 2017; 38(3):238-244. PubMed ID: 27485810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE SPECTRUM OF INTERNAL LIMITING MEMBRANE DISEASE IN ALPORT SYNDROME: A Multimodal Imaging Study.
    Cicinelli MV; Ritter M; Ghossein C; Aschauer C; Laccone F; Nagel M; Schmidt-Erfurth UM; Jampol LM; Gill MK
    Retina; 2022 Feb; 42(2):274-282. PubMed ID: 34483311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New macular tomography findings in Alport syndrome].
    Dolz-Marco R; Gallego-Pinazo R; Francés-Muñoz E; Martínez-Castillo S; Díaz-Llopis M
    Arch Soc Esp Oftalmol; 2012 Feb; 87(2):55-6. PubMed ID: 22341361
    [No Abstract]   [Full Text] [Related]  

  • 7. Temporal retinal thinning and the diagnosis of Alport syndrome and Thin basement membrane nephropathy.
    Chen Y; Colville D; Ierino F; Symons A; Savige J
    Ophthalmic Genet; 2018 Apr; 39(2):208-214. PubMed ID: 29172845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between En Face Optical Coherence Tomography Defects of the Inner Retinal Layers and Ganglion Cell Inner Plexiform Layer Analysis After Internal Limiting Membrane Peeling for Idiopathic Full-Thickness Macular Hole.
    Sabry D; El-Kannishy A; Kamel R; Abou Samra W
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT444-50. PubMed ID: 27409504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tapetal-like sheen associated with fleck retinopathy in Alport syndrome.
    Cervantes-Coste G; Fuentes-Paez G; Yeshurun I; Jimenez-Sierra JM
    Retina; 2003 Apr; 23(2):245-7. PubMed ID: 12707609
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rare ocular manifestation with suspect alport syndrome].
    Krejčířová I; Varadyová B; Doležel Z; Autrata R; Matúšová J; Gregorová E
    Cesk Slov Oftalmol; 2014 Jun; 70(3):114-8. PubMed ID: 25032798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new case of giant macular hole in a patient with Alport syndrome].
    Mercé E; Korobelnik JF; Delyfer MN; Rougier MB
    J Fr Ophtalmol; 2012 Oct; 35(8):573-9. PubMed ID: 22695059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroretinographic abnormalities in Alport syndrome with a novel COL4A5 truncated variant (p.Try20GlyfsTer19).
    Mizobuchi K; Hayashi T; Ohira R; Nakano T
    Doc Ophthalmol; 2023 Jun; 146(3):281-291. PubMed ID: 37162688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral giant macular hole in a case of Alport syndrome.
    Panchal B; Doshi S; Pathengay A
    Indian J Ophthalmol; 2019 Oct; 67(10):1731. PubMed ID: 31546540
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-function correlation of focal and diffuse temporal perifoveolar thinning in Alport syndrome.
    Wong EN; Tay-Kearney ML; Chen FK
    Clin Exp Ophthalmol; 2014; 42(7):699-702. PubMed ID: 24119173
    [No Abstract]   [Full Text] [Related]  

  • 15. Macular spectral domain optical coherence tomography findings in Tanzanian endemic optic neuropathy.
    Kisimbi J; Shalchi Z; Mahroo OA; Mhina C; Sanyiwa AJ; Mabey D; Mohamed M; Plant GT
    Brain; 2013 Nov; 136(Pt 11):3418-26. PubMed ID: 24018312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Coherence Tomography Angiography and En Face Optical Coherence Tomography Features of Paracentral Acute Middle Maculopathy.
    Sridhar J; Shahlaee A; Rahimy E; Hong BK; Khan MA; Maguire JI; Dunn JP; Mehta S; Ho AC
    Am J Ophthalmol; 2015 Dec; 160(6):1259-1268.e2. PubMed ID: 26386158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal retinal thinning and increased foveal avascular zone blood vessel density in alport syndrome: a case report.
    Borgman CJ; Duncan J; Martinez M
    Clin Exp Optom; 2021 Nov; 104(8):874-875. PubMed ID: 33689638
    [No Abstract]   [Full Text] [Related]  

  • 18. It is an Alport syndrome, not a simple hypertensive retinopathy.
    Gadde AK; Srirampur A; Manwani S; Agraharam S
    Indian J Ophthalmol; 2018 Sep; 66(9):1319-1321. PubMed ID: 30127153
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical features and pathogenesis of Alport retinopathy.
    Gehrs KM; Pollock SC; Zilkha G
    Retina; 1995; 15(4):305-11. PubMed ID: 8545576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opinion: Ocular features aid the diagnosis of Alport syndrome.
    Savige J; Colville D
    Nat Rev Nephrol; 2009 Jun; 5(6):356-60. PubMed ID: 19474829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.